Open AccessEffect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes
Author(s) -
Wendy Lane,
Timothy S. Bailey,
Gregg Gerety,
Janusz Gumprecht,
Athena PhilisTsimikas,
Charlotte T. Hansen,
Thor S.S. Nielsen,
Mark Warren
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.7115
Subject(s) - medicine , insulin glargine , hypoglycemia , insulin degludec , insulin , glycemic , type 2 diabetes , morning , diabetes mellitus , randomized controlled trial , pediatrics , endocrinology
Hypoglycemia, common in patients with type 1 diabetes, is a major barrier to achieving good glycemic control. Severe hypoglycemia can lead to coma or death.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom